Thomas Bures - Net Worth and Insider Trading

Thomas Bures Net Worth

The estimated net worth of Thomas Bures is at least $200,230 dollars as of 2026-08-18. Thomas Bures is the Chief Accounting Officer of Bruker Corp and owns about 3,472 shares of Bruker Corp (BRKR) stock worth over $200,230. Details can be seen in Thomas Bures's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas Bures has not made any transactions after 2025-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Thomas Bures

Are these stocks worth buying? — GuruFocus analysis for each holding

- GF

BRKR Bruker Corp

100% of holdings · $200K

Thomas Bures Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Bures owns 3 companies in total, including Pieris Pharmaceuticals Inc (PIRS) , Bruker Corp (BRKR) , and Palvella Therapeutics Inc (PVLA) .

Click here to see the complete history of Thomas Bures’s form 4 insider trades.

Insider Ownership Summary of Thomas Bures

Ticker	Company	Transaction Date	Type of Owner
PIRS	Pieris Pharmaceuticals Inc	2023-02-24	Chief Financial Officer
BRKR	Bruker Corp	2025-01-13	Chief Accounting Officer
PVLA	Palvella Therapeutics Inc	2023-02-24	Chief Financial Officer

Thomas Bures Latest Holdings Summary

Thomas Bures currently owns a total of 1 stock. Thomas Bures owns 3,472 shares of Bruker Corp (BRKR) as of March 10, 2025, with a value of $200,230.

Latest Holdings of Thomas Bures

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BRKR	Bruker Corp	2025-03-10	3,472	57.67	200,230

Holding Weightings of Thomas Bures

Thomas Bures Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Bures has made a total of 1 transactions in Bruker Corp (BRKR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bruker Corp is the acquisition of 500 shares on March 10, 2025, which cost Thomas Bures around $23,700.

Insider Trading History of Thomas Bures

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Bures Trading Performance

GuruFocus tracks the stock performance after each of Thomas Bures's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas Bures is -14.22%. GuruFocus also compares Thomas Bures's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas Bures within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas Bures's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas Bures

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-19.68
Relative Return to S&P 500(%)	-13.51

Get the full picture on these stocks

See GF Score, valuation, financials, and warning signs for every stock Thomas Bures owns.

- BRKR

View BRKR Analysis

Thomas Bures Ownership Network

Ownership Network List of Thomas Bures

No Data

Ownership Network Relation of Thomas Bures

Thomas Bures Owned Company Details

What does Pieris Pharmaceuticals Inc do?

Who are the key executives at Pieris Pharmaceuticals Inc?

Thomas Bures is the Chief Financial Officer of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .

Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pieris Pharmaceuticals Inc Insider Transactions

No Available Data

What does Bruker Corp do?

Who are the key executives at Bruker Corp?

Thomas Bures is the Chief Accounting Officer of Bruker Corp. Other key executives at Bruker Corp include Pres. Bruker Nano Inc. Mark Munch , President BMID Group Wolfgang Pusch , and director & 10 percent owner & PRESIDENT & CEO Frank H Laukien .

Bruker Corp (BRKR) Insider Trades Summary

Over the past 18 months, Thomas Bures made 1 insider transaction in Bruker Corp (BRKR) with a net purchase of 500. Other recent insider transactions involving Bruker Corp (BRKR) include a net sale of 54,843 shares made by Mark Munch , a net sale of 6,233 shares made by John A Ornell , and a net sale of 5,028 shares made by Richard A Packer .

In summary, during the past 3 months, insiders sold 4,000 shares of Bruker Corp (BRKR) in total and bought 0 shares, with a net sale of 4,000 shares. During the past 18 months, 69,639 shares of Bruker Corp (BRKR) were sold and 3,108 shares were bought by its insiders, resulting in a net sale of 66,531 shares.

Bruker Corp (BRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bruker Corp Insider Transactions

No Available Data

What does Palvella Therapeutics Inc do?

Who are the key executives at Palvella Therapeutics Inc?

Thomas Bures is the Chief Financial Officer of Palvella Therapeutics Inc. Other key executives at Palvella Therapeutics Inc include Chief Operating Officer Kathleen Goin , Chief Commercial Officer Ashley Hartmann Kline , and Chief Operating Officer Palvella Therapeutics, Inc. .

Palvella Therapeutics Inc (PVLA) Insider Trades Summary

Over the past 18 months, Thomas Bures made no insider transaction in Palvella Therapeutics Inc (PVLA). Other recent insider transactions involving Palvella Therapeutics Inc (PVLA) include a net sale of 34,416 shares made by Kathleen Goin , a net purchase of 9,435 shares made by George M Jenkins , and a net purchase of 2,400 shares made by Elaine J Heron .

In summary, during the past 3 months, insiders sold 12,906 shares of Palvella Therapeutics Inc (PVLA) in total and bought 0 shares, with a net sale of 12,906 shares. During the past 18 months, 34,416 shares of Palvella Therapeutics Inc (PVLA) were sold and 11,835 shares were bought by its insiders, resulting in a net sale of 22,581 shares.

Palvella Therapeutics Inc (PVLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Palvella Therapeutics Inc Insider Transactions

No Available Data

Thomas Bures Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Bures. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Thomas Bures's mailing address is: Boston Ma 02109.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.